Tecon Biology Co Ltd
SZSE:002100
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.71
8.94
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Tecon Biology Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 8.9B CNY |
| Net Margin |
-2%
|
| Country | US |
| Market Cap | 24.5B EUR |
| Net Margin |
3%
|
| Country | CN |
| Market Cap | 117B CNY |
| Net Margin |
-3%
|
| Country | SA |
| Market Cap | 55.2B SAR |
| Net Margin | N/A |
| Country | SG |
| Market Cap | 19.2B SGD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 12.7B USD |
| Net Margin |
4%
|
| Country | US |
| Market Cap | 9.5B USD |
| Net Margin |
9%
|
| Country | MY |
| Market Cap | 33.6B MYR |
| Net Margin |
10%
|
| Country | US |
| Market Cap | 6.4B USD |
| Net Margin |
4%
|
| Country | CN |
| Market Cap | 43B CNY |
| Net Margin |
2%
|
| Country | MY |
| Market Cap | 23.6B MYR |
| Net Margin |
12%
|
Tecon Biology Co Ltd
Glance View
Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. The company is headquartered in Urumqi, Xinjiang and currently employs 5,669 full-time employees. The company went IPO on 2006-12-26. The firm's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The firm mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Tecon Biology Co Ltd's most recent financial statements, the company has Net Margin of -1.7%.
You don't have any saved screeners yet
